Thyroid hormone influences brain gene expression programs and behaviors in later generations by altering germ line epigenetic information


Genetic factors do not fully account for the relatively high heritability of neurodevelopmental conditions, suggesting that non-genetic heritable factors contribute to their etiology. To evaluate the potential contribution of aberrant thyroid hormone status to the epigenetic inheritance of neurological phenotypes, we examined genetically normal F2 generation descendants of mice that were developmentally overexposed to thyroid hormone due to a Dio3 mutation. Hypothalamic gene expression profiling in postnatal day 15 F2 descendants on the paternal lineage of ancestral male and female T3-overexposed mice revealed, respectively, 1089 and 1549 differentially expressed genes. A large number of them, 675 genes, were common to both sets, suggesting comparable epigenetic effects of thyroid hormone on both the male and female ancestral germ lines. Oligodendrocyte- and neuron-specific genes were strongly overrepresented among genes showing, respectively, increased and decreased expression. Altered gene expression extended to other brain regions and was associated in adulthood with decreased anxiety-like behavior, increased marble burying and reduced physical activity. The sperm of T3-overexposed male ancestors revealed significant hypomethylation of CpG islands associated with the promoters of genes involved in the early development of the central nervous system. Some of them were candidates for neurodevelopmental disorders in humans including Nrg3, Nrxn1, Gabrb3, Gabra5, Apba2, Grik3, Reln, Nsd1, Pcdh8, En1, and Elavl2. Thus, developmental levels of thyroid hormone influence the epigenetic information of the germ line, disproportionately affecting genes with critical roles in early brain development, and leading in future generations to disease-relevant alterations in postnatal brain gene expression and adult behavior.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5


  1. 1.

    Gupta AR, State MW. Recent advances in the genetics of autism. Biol Psychiatry. 2007;61:429–37.

  2. 2.

    Sullivan PF. The genetics of schizophrenia. PLoS Med. 2005;2:e212.

  3. 3.

    Butler MG, McGuire AB, Masoud H, Manzardo AM. Currently recognized genes for schizophrenia: high-resolution chromosome ideogram representation. Am J Med Genet B Neuropsychiatr Genet. 2016;171b:181–202.

  4. 4.

    Sandin S, Lichtenstein P, Kuja-Halkola R, Hultman C, Larsson H, Reichenberg A. The heritability of Autism spectrum disorder. JAMA. 2017;318:1182–4.

  5. 5.

    de Zeeuw EL, van Beijsterveldt CEM, Hoekstra RA, Bartels M, Boomsma DI. The etiology of autistic traits in preschoolers: a population-based twin study. J Child Psychol Psychiatry. 2017;58:893–901.

  6. 6.

    Tick B, Bolton P, Happe F, Rutter M, Rijsdijk F. Heritability of autism spectrum disorders: a meta-analysis of twin studies. J Child Psychol Psychiatry. 2016;57:585–95.

  7. 7.

    Yip BHK, Bai D, Mahjani B, Klei L, Pawitan Y, Hultman CM et al. Heritable Variation, With Little or No Maternal Effect, Accounts for Recurrence Risk to Autism Spectrum Disorder in Sweden. Biol Psychiatry. 2018;83:589–97.

  8. 8.

    Chen JA, Penagarikano O, Belgard TG, Swarup V, Geschwind DH. The emerging picture of autism spectrum disorder: genetics and pathology. Annu Rev Pathol. 2015;10:111–44.

  9. 9.

    Huguet G, Benabou M, Bourgeron T The Genetics of Autism Spectrum Disorders. In: Sassone-Corsi P, Christen Y (eds). A Time for Metabolism and Hormones. Springer Copyright 2016, The Author(s). Cham (CH), 2016, pp 101–29.

  10. 10.

    Bourgeron T. Current knowledge on the genetics of autism and propositions for future research. C R Biol. 2016;339:300–7.

  11. 11.

    Ziats MN, Rennert OM. The evolving diagnostic and genetic landscapes of Autism spectrum disorder. Front Genet. 2016;7:65.

  12. 12.

    De Rubeis S, Buxbaum JD. Genetics and genomics of autism spectrum disorder: embracing complexity. Hum Mol Genet. 2015;24(R1):R24–31.

  13. 13.

    Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006;29:349–58.

  14. 14.

    Kinney DK, Munir KM, Crowley DJ, Miller AM. Prenatal stress and risk for autism. Neurosci & Biobehav Rev. 2008;32:1519–32.

  15. 15.

    Molloy CA, Morrow AL, Meinzen-Derr J, Dawson G, Bernier R, Dunn M, et al. Familial autoimmune thyroid disease as a risk factor for regression in children with Autism Spectrum Disorder: a CPEA Study. J Autism & Dev Disord. 2006;36:317–24.

  16. 16.

    Dunaway KW, Islam MS, Coulson RL, Lopez SJ, Vogel Ciernia A, Chu RG, et al. Cumulative Impact of Polychlorinated Biphenyl and Large Chromosomal Duplications on DNA Methylation, Chromatin, and Expression of Autism Candidate Genes. Cell Rep. 2016;17:3035–48.

  17. 17.

    Vineis P, Pearce N. Missing heritability in genome-wide association study research. Nat Rev Genet. 2010;11:589.

  18. 18.

    Shen X. The curse of the missing heritability. Front Genet. 2013;4:225.

  19. 19.

    Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. [Review] [84 refs]. Nature. 2009;461:747–53.

  20. 20.

    Trerotola M, Relli V, Simeone P, Alberti S. Epigenetic inheritance and the missing heritability. Hum Genom. 2015;9:17.

  21. 21.

    Koch L. Disease genetics: insights into missing heritability. Nat Rev Genet. 2014;15:218.

  22. 22.

    Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011;88:294–305. 88(3):294–305, 2011 Mar 11

  23. 23.

    Yuan TF, Li A, Sun X, Ouyang H, Campos C, Rocha NB et al. Transgenerational inheritance of paternal neurobehavioral phenotypes: stress, addiction, ageing and metabolism. Mol Neurobiol. 2016;53:6367–76.

  24. 24.

    Bohacek J, Mansuy IM. Molecular insights into transgenerational non-genetic inheritance of acquired behaviours. Nat Rev Genet. 2015;16:641–52.

  25. 25.

    Wei Y, Yang CR, Wei YP, Zhao ZA, Hou Y, Schatten H, et al. Paternally induced transgenerational inheritance of susceptibility to diabetes in mammals. Proc Natl Acad Sci USA. 2014;111:1873–8.

  26. 26.

    Skinner MK, Guerrero-Bosagna C, Haque M, Nilsson E, Bhandari R, McCarrey JR. Environmentally induced transgenerational epigenetic reprogramming of primordial germ cells and the subsequent germ line. PLoS ONE. 2013;8:e66318.

  27. 27.

    Bernal J. Thyroid hormones and brain development. Vitam & Horm. 2005;71:95–122.

  28. 28.

    Refetoff S, Weiss RE, Usala S. The syndromes of resistance to thyroid hormones. Endo Rev. 1993;14:348–99.

  29. 29.

    Kempers MJE, van Tijn DA, van Trotsenburg ASP, de Vijlder JJM, Wiedijk BM. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab. 2003;88:5851–7.

  30. 30.

    Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010;123:183.e181–189.

  31. 31.

    McLachlan SM, Rapoport B. Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev. 2014;35:59–105.

  32. 32.

    Giera S, Bansal R, Ortiz-Toro TM, Taub DG, Zoeller RT. Individual polychlorinated biphenyl (PCB) congeners produce tissue- amd genespecific effects on thyroid hormone signaling during development. Endocrinology. 2011;152:2909–19.

  33. 33.

    Bansal R, Tighe D, Danai A, Rawn DF, Gaertner DW, Arnold DL, et al. Polybrominated diphenyl ether (DE-71) interferes with thyroid hormone action independent of effects on circulating levels of thyroid hormone in male rats. Endocrinology. 2014;155:4104–12.

  34. 34.

    Legrand J. Effects of thyroid hormones on central nervous system development. In: Yanai J, (ed). Neurobehavioral Teratology.. New York: Elsevier; 1984. p. 331–63.

  35. 35.

    Calvo R, Obregón MJ, Ruiz de Ona C, Escobar del Rey F, de Escobar GM. Congenital hypothyroidism, as studied in rats: crucial role of maternal thyroxine but not 3,5,3’-triiodothyronine in the protection of the fetal brain. J Clin Invest. 1990;86:889–99.

  36. 36.

    Crawford S, van Baar AL, Brouwers EP, Pop VJ. Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics. 2006;117:161–7.

  37. 37.

    Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Eng J Med. 1996;334:821–7.

  38. 38.

    Andersen SL, Laurberg P, Wu CS, Olsen J. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG. 2014;121:1365–74.

  39. 39.

    Khan A, Harney JW, Zavacki AM, Sajdel-Sulkowska EM. Disrupted brain thyroid hormone homeostasis and altered thyroid hormone-dependent brain gene expression in autism spectrum disorders. J Physiol Pharmacol. 2014;65:257–72.

  40. 40.

    Sadamatsu M, Kanai H, Xu X, Liu Y, Kato N. Review of animal models for autism: implication of thyroid hormone. Congenit Anom (Kyoto). 2006;46:1–9.

  41. 41.

    Gyllenberg D, Sourander A, Surcel HM, Hinkka-Yli-Salomaki S, McKeague IW, Brown ASHypothyroxinemiaDuringGestation. and Offspring Schizophrenia in a National Birth Cohort. Biol Psychiatry. 2016;79:962–70.

  42. 42.

    Modesto T, Tiemeier H, Peeters RP, Jaddoe VW, Hofman A, Verhulst FC, et al. Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children. JAMA Pediatr. 2015;169:838–45.

  43. 43.

    Bakke JL, Lawrence NL, Robinson S, Bennett J. Observations on the untreated progeny of hypothyroid male rats. Metab: Clin & Exp. 1976;25:437–44.

  44. 44.

    Bakke JL, Lawrence NL, Robinson S, Bennett J. Endocrine studies in the untreated F1 and F2 progeny of rats treated neonatally with thyroxine. Biol Neonate. 1977;31:71–83.

  45. 45.

    Tunc-Ozcan E, Wert SL, Lim PH, Ferreira A, Redei EE. Hippocampus-dependent memory and allele-specific gene expression in adult offspring of alcohol-consuming dams after neonatal treatment with thyroxin or metformin. Mol Psychiatry. 2018;23:1643–51.

  46. 46.

    Tunc-Ozcan E, Harper KM, Graf EN, Redei EE. Thyroxine administration prevents matrilineal intergenerational consequences of in utero ethanol exposure in rats. Horm Behav. 2016;82:1–10.

  47. 47.

    Hernandez A, Martinez ME, Fiering S, Galton VA, St Germain D. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Investig. 2006;116:476–84.

  48. 48.

    Hernandez A. Structure and function of the type 3 deiodinase gene. Thyroid: Off J Am Thyroid Assoc. 2005;15:865–74.

  49. 49.

    Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O’Keeffe S, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci: Off J Soc Neurosci. 2014;34:11929–47.

  50. 50.

    Osborne JD, Flatow J, Holko M, Lin SM, Kibbe WA, Zhu LJ, et al. Annotating the human genome with Disease Ontology. BMC Genom. 2009;10(Suppl 1):S6.

  51. 51.

    Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics. 2007;23:257–8.

  52. 52.

    Du P, Feng G, Flatow J, Song J, Holko M, Kibbe WA, et al. From disease ontology to disease-ontology lite: statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations. Bioinformatics. 2009;25:i63–68.

  53. 53.

    Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3.

  54. 54.

    Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.

  55. 55.

    Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13.

  56. 56.

    Martinez ME, Charalambous M, Saferali A, Fiering S, Naumova AK, St Germain D, et al. Genomic imprinting variations in the mouse type 3 deiodinase gene between tissues and brain regions. Mol Endocrinol. 2014;28:1875–86.

  57. 57.

    Hernandez A, Fiering S, Martinez E, Galton VA, St Germain D. The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts. Endocrinology. 2002;143:4483–6.

  58. 58.

    Tsai C, Lin SP, Ito M, Takagi N, Ferguson-Smith ST, Genomic AC. Imprinting contributes to thyroid hormone metabolism in the mouse embryo. Curr Biol. 2002;12:1221–6.

  59. 59.

    Sittig LJ, Herzing LBK, Shukla PK, Redei EE. Parent-of-origin allelic contributions to deiodinase-3 expression elicit localized hyperthyroid milieu in the hippocampus. Mol Psychiatry. 2011;16:786–7.

  60. 60.

    Ueta CintiaB, Behzad, Oskouei N, Jose ELO. R Pinto, Mayrin M Correa, Gordana Simovic, Warner S Simonides, Joshua M Hare, Antonio C Bianco. Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice. Mol Endocrinol. 2012;26:809–18.

  61. 61.

    Barez-Lopez S, Obregon MJ, Bernal J, Guadano-Ferraz A. Thyroid hormone economy in the perinatal mouse brain: implications for cerebral cortex development. Cereb Cortex. 2018;28:1783–93.

  62. 62.

    Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S, et al. A map of the cis-regulatory sequences in the mouse genome. Nature. 2012;488:116–20.

  63. 63.

    Chatonnet F, Flamant F, Morte B. A temporary compendium of thyroid hormone target genes in brain. Biochim Biophys Acta. 2015;1849:122–9.

  64. 64.

    Hernandez A, Quignodon L, Martinez ME, Flamant F, St. Germain DL. Type 3 deiodinase deficiency causes spatial an temporal alterations in brain T3 signaling that are dissociated from serum thyroid hormone levels. Endocrinology. 2010;151:5550–8.

  65. 65.

    Stohn JP, Martinez ME, Hernandez A. Decreased anxiety- and depression-like behaviors and hyperactivity in a type 3 deiodinase-deficient mouse showing brain thyrotoxicosis and peripheral hypothyroidism. Psychoneuroendocrinology. 2016;74:46–56.

  66. 66.

    Martinez ME, Karaczyn A, Stohn JP, Donnelly WT, Croteau W, Peeters RP, et al. The Type 3 deiodinase is a critical determinant of appropriate thyroid hormone action in the developing testis. Endocrinology. 2016;157:1276–88.

  67. 67.

    Pascual A, Aranda A. Thyroid hormone receptors, cell growth and differentiation. Biochim Biophys Acta. 2013;1830:3908–16.

  68. 68.

    Kyono Y, Subramani A, Ramadoss P, Hollenberg AN, Bonett RM, Denver RJ. Liganded thyroid hormone receptors transactivate the DNA methyltransferase 3a gene in mouse neuronal cells. Endocrinology. 2016;157:3647–57.

  69. 69.

    Fonseca TL, Fernandes GW, McAninch EA, Bocco BM, Abdalla SM, Ribeiro MO, et al. Perinatal deiodinase 2 expression in hepatocytes defines epigenetic susceptibility to liver steatosis and obesity. Proc Natl Acad Sci USA. 2015;112:14018–23.

  70. 70.

    Amador-Arjona A, Cimadamore F, Huang CT, Wright R, Lewis S, Gage FH, et al. SOX2 primes the epigenetic landscape in neural precursors enabling proper gene activation during hippocampal neurogenesis. Proc Natl Acad Sci USA. 2015;112:E1936–1945.

  71. 71.

    Lopez-Juarez A, Remaud S, Hassani Z, Jolivet P, Pierre Simons J, Sontag T, et al. Thyroid hormone signaling acts as a neurogenic switch by repressing Sox2 in the adult neural stem cell niche. Cell Stem Cell. 2012;10:531–43.

  72. 72.

    Memic F, Knoflach V, Sadler R, Tegerstedt G, Sundstrom E, Guillemot F, et al. Ascl1 Is required for the development of specific neuronal subtypes in the enteric nervous system. J Neurosci: Off J Soc Neurosci. 2016;36:4339–50.

  73. 73.

    Gulacsi AA, Anderson SA. Beta-catenin-mediated Wnt signaling regulates neurogenesis in the ventral telencephalon. Nat Neurosci. 2008;11:1383–91.

  74. 74.

    Mozzi A, Guerini FR, Forni D, Costa AS, Nemni R, Baglio F, et al. REST, a master regulator of neurogenesis, evolved under strong positive selection in humans and in non human primates. Sci Rep. 2017;7:9530.

  75. 75.

    Bianco AC. Minireview: cracking the metabolic code for thyroid hormone signaling. Endocrinology. 2011;152:3306–11.

  76. 76.

    Remaud S, Ortiz FC, Perret-Jeanneret M, Aigrot MS, Gothie JD, Fekete C et al. Transient hypothyroidism favors oligodendrocyte generation providing functional remyelination in the adult mouse brain. Elife 2017; 6. e29996.

Download references


We are grateful to Joseph Nadeau for his critical review of the manuscript and to Amanda Drake for technical advice. This study was supported by grants MH096050 and DK095908 from the National Institute of Mental Health and National Institute of Diabetes, Digestive and Kidney Diseases, respectively. This work used the Confocal Microscopy Core, the Histopathology Core, the Physiology Core and the Molecular Phenotyping Core at Maine Medical Center Research Institute, that are supported by grants P30GM106391, P30GM103392, P20GM121301, and U54GM115516 from the National Institute of General Medical Sciences.

Author information



Corresponding author

Correspondence to Arturo Hernandez.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Martinez, M.E., Duarte, C.W., Stohn, J.P. et al. Thyroid hormone influences brain gene expression programs and behaviors in later generations by altering germ line epigenetic information. Mol Psychiatry 25, 939–950 (2020).

Download citation

Further reading